Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

A Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim (Dulastin®) after Single Administration in Pediatric Patients

Kyung Taek Hong, MD, Soyoung Lee, Jaeseong Oh, Jung Yoon Choi, MD, Hee Young Shin, MD PhD, Kyung-Sang Yu, MD PhD, Hyoung Jin Kang, MD PhD

Blood (2019) 134 (Supplement_1): 3594.

https://doi.org/10.1182/blood-2019-125266

Published: 2019

Journal Articles

Comparison of Haploidentical Transplantation with Post-Transplantation Cyclophosphamide and Umbilical Cord Blood Transplantation in Children and Adolescents with Hematologic Malignancies after Targeted Busulfan-Based Myeloablative Conditioning Using Intensive Pharmacokinetic Monitoring

Kyung Taek Hong, MD, Hyoung Jin Kang, MD PhD, Hong Yul Ahn, MD, Jung Yoon Choi, MD, Sang Hoon Song, MD PhD, Kyung-Sang Yu, MD PhD, In-Jin Jang, MD PhD, Hee Young Shin, MD PhD

Blood (2018) 132 (Supplement 1): 2163.

https://doi.org/10.1182/blood-2018-99-112090

Published: 2018

Journal Articles

Analysis of Genetic Variants Related to the Hepatic Veno-Occlusive Disease in Pediatric Patients Receiving HSCT with Targeted Dose Busulfan Based Conditioning

Jung Yoon Choi, MD, Heewon Seo, Yoomi Park, ByungJoo Min, Hyery Kim, MD, Kyung Taek Hong, MD, Che Ry Hong, MD, Sang Hoon Song, MD, Kyung-Sang Yu, MD, In-Jin Jang, MD, Kyung Duk Park, MD, Hee Young Shin, MD, Ju Han Kim, MD, Hyoung Jin Kang, MD

Blood (2017) 130 (Supplement 1): 1963.

https://doi.org/10.1182/blood.V130.Suppl_1.1963.1963

Published: 2017

Journal Articles

Pharmacokinetic Analysis of Continuous Intravenous Infusion of Lipo-Prostaglandin E1 As a Prophylaxis of Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation

Che Ry Hong, Yewon Choi, Jaeseong Oh, Jung Sunwoo, Kyung Taek Hong, Jung Yoon Choi, Kyung-Sang Yu, Kyung Duk Park, MD PhD, Hee Young Shin, MD PhD, Hyoung Jin Kang, MD PhD

Blood (2016) 128 (22): 2214.

https://doi.org/10.1182/blood.V128.22.2214.2214

Published: 2016

Journal Articles

Pharmacometabolomics for Predicting Variable Busulfan Exposure in Pediatric HSCT Patients

Bora Kim, Kyung Taek Hong, Ji Won Lee, Kyung-Sang Yu, In-Jin Jang, Kyung Duk Park, MD PhD, Hee Young Shin, MD PhD, Hyo Seop Ahn, Joo-Youn Cho, Hyoung Jin Kang, MD PhD

Blood (2016) 128 (22): 2218.

https://doi.org/10.1182/blood.V128.22.2218.2218

Published: 2016

Journal Articles

Pharmacokinetics of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation

Hee Young Ju, Ji Won Lee, Che Ry Hong, Hyery Kim, Kyung Duk Park, Hee Young Shin, Seokuee Kim, Kyungho Jang, Kyung-Sang Yu, In-Jin Jang, Hyoung Jin Kang

Blood (2014) 124 (21): 2466.

https://doi.org/10.1182/blood.V124.21.2466.2466

Published: 2014

Journal Articles

Favorable Outcome Of Hematopoietic Stem Cell Transplantation Using a Targeted Once-Daily IV Busulfan Fludarabine Etoposide Regimen In Pediatric and Infant ALL Patients

Hyoung Jin Kang, Ji Won Lee, Sung jin Kim, Seung Hwan Lee, Kyung-Sang Yu, Nam Hee Kim, Mi Kyoung Jang, Hyery Kim, Sang Hoon Song, Kyung Duk Park, Hee Young Shin, In-Jin Jang, Hyo Seop Ahn

Blood (2013) 122 (21): 4553.

https://doi.org/10.1182/blood.V122.21.4553.4553

Published: 2013

Journal Articles

Successful Empirical Antifungal Therapy of Intravenous Itraconazole with Pharmacokinetic Evidence in Pediatric Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation

Hyery Kim, Donghoon Shin, Ji Won Lee, Mi Kyoung Jang, Kyung Duk Park, Hee Young Shin, Hyo Seop Ahn, Kyung-Sang Yu, Hyoung Jin Kang

Blood (2011) 118 (21): 3019.

https://doi.org/10.1182/blood.V118.21.3019.3019

Published: 2011

Journal Articles

Unpredictable Pharmacokinetics of Once-Daily Intravenous Busulfan When Combined with Fludarabine in Pediatric Patients: Phase I Clinical Study for Determination of Optimal Once-Daily Busulfan Dose Using Pharmacokinetic Modeling.

Ji Won Lee, Hyoung Jin Kang, SeungHwan Lee, Kyung-Sang Yu, Nam Hee Kim, Yen Ju Yuk, Mi Kyoung Jang, Eun Jong Han, Hyery Kim, In-Jin Jang, Hee Young Shin, Hyo Seop Ahn

Blood (2009) 114 (22): 1184.

https://doi.org/10.1182/blood.V114.22.1184.1184

Published: 2009

NARROW

A Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim (Dulastin®) after Single Administration in Pediatric Patients

Comparison of Haploidentical Transplantation with Post-Transplantation Cyclophosphamide and Umbilical Cord Blood Transplantation in Children and Adolescents with Hematologic Malignancies after Targeted Busulfan-Based Myeloablative Conditioning Using Intensive Pharmacokinetic Monitoring

Analysis of Genetic Variants Related to the Hepatic Veno-Occlusive Disease in Pediatric Patients Receiving HSCT with Targeted Dose Busulfan Based Conditioning

Pharmacokinetic Analysis of Continuous Intravenous Infusion of Lipo-Prostaglandin E1 As a Prophylaxis of Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation

Pharmacometabolomics for Predicting Variable Busulfan Exposure in Pediatric HSCT Patients

Pharmacokinetics of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation

Favorable Outcome Of Hematopoietic Stem Cell Transplantation Using a Targeted Once-Daily IV Busulfan Fludarabine Etoposide Regimen In Pediatric and Infant ALL Patients

Successful Empirical Antifungal Therapy of Intravenous Itraconazole with Pharmacokinetic Evidence in Pediatric Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation

Unpredictable Pharmacokinetics of Once-Daily Intravenous Busulfan When Combined with Fludarabine in Pediatric Patients: Phase I Clinical Study for Determination of Optimal Once-Daily Busulfan Dose Using Pharmacokinetic Modeling.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only